Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT04758767 |
| Title | CID-103 (Anti-CD38 Antibody) in Previously Treated Relapsed or Refractory Multiple Myeloma |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | CASI Pharmaceuticals, Inc. |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | GBR | FRA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| CHU de Nantes - Hôpital Hôtel-Dieu | Nantes | France | Details | |||
| CHU Rennes - Pontchaillou | Rennes | France | Details | |||
| Gustave Roussy Cancer Center | Villejuif Cedex | France | Details | |||
| Sarah Cannon | London | United Kingdom | Details |